Description
FEXOFIN-M Suspension is a pediatric-grade oral formulation developed by ANVIS, combining two well-established active ingredients—Fexofenadine Hydrochloride (30 mg) and Montelukast Sodium (4 mg)—in a 60 ml bottle. This dual-action antihistaminic and leukotriene receptor antagonist formula is designed to provide effective relief from seasonal allergic rhinitis, hay fever, and chronic allergic symptoms in children.
Fexofenadine offers non-sedative, long-acting antihistamine benefits, helping to reduce sneezing, nasal discharge, itching, and hives. Montelukast complements this action by targeting leukotrienes that contribute to airway inflammation, thereby controlling allergic triggers and minimizing asthma-related symptoms such as wheezing and bronchial tightness.
The formulation is suitable for children who suffer from recurring allergy symptoms and is particularly helpful during pollen-heavy seasons or in urban environments with high irritant exposure. FEXOFIN-M Suspension is flavored to enhance pediatric compliance and comes with clear dosage guidelines to ensure safe and precise administration. Manufactured by ANVIS under stringent pharmaceutical standards, this syrup integrates smoothly into pediatric care plans for allergy management.
